Andrew Newton 
ADVERTISEMENT
Most Read on APEsphere
Most Commented on APEsphere
Blogs we like
Resources
Vioxx and Celebrex study data faked
Add this link to:
Related Links
Report Abuse:
So that we can keep the site friendly, legal and on-topic, please click the Report Abuse button if this story breaks the APEsphere Code.
Added by
apesphere on 11 Mar 2009
From: blogs.wsj.com
|
| Image courtesy jbcurio via Flickr |
Twenty one drug studies undertaken by an acute pain specialist at Baystate Medical Center in Springfield, Mass., were based on faked data.
Doctor Scott S. Reuben's research provided favorable results on Pfizer’s Bextra and Merck’s Vioxx, both painkillers that have since been pulled from the market, reports the Wall Street Journal Blog.
His research has been highly influential, doctors contacted by the newspaper said.
From the Wall Street Journal blog:
"Pfizer had funded some of Reuben’s research and had also paid him to speak on behalf of its medicines. “It is very disappointing to learn about Dr. Scott Reuben’s alleged actions,” Pfizer said in a statement to WSJ. “When we decided to support Dr. Reuben’s research, he worked for a credible academic medical center and appeared to be a reputable investigator.”"
Seems like a testament to the corrupting power of Big Pharma's marketing money.
Doctor Scott S. Reuben's research provided favorable results on Pfizer’s Bextra and Merck’s Vioxx, both painkillers that have since been pulled from the market, reports the Wall Street Journal Blog.
His research has been highly influential, doctors contacted by the newspaper said.
From the Wall Street Journal blog:
"Pfizer had funded some of Reuben’s research and had also paid him to speak on behalf of its medicines. “It is very disappointing to learn about Dr. Scott Reuben’s alleged actions,” Pfizer said in a statement to WSJ. “When we decided to support Dr. Reuben’s research, he worked for a credible academic medical center and appeared to be a reputable investigator.”"
Seems like a testament to the corrupting power of Big Pharma's marketing money.
Andrew Newton is the author of The Handbook of Compliance: Making Ethics Work in Financial Services
Comments
Add a comment